Marion van Mackelenbergh Selected Research

Marion van Mackelenbergh Research Topics

Disease

24	Breast Neoplasms (Breast Cancer) 02/2024 - 10/2013
12	Neoplasms (Cancer) 11/2023 - 10/2013
6	Triple Negative Breast Neoplasms 10/2021 - 01/2018
5	Pathologic Complete Response 11/2023 - 01/2021
1	Lymphatic Metastasis 02/2024
1	Amenorrhea 01/2021
1	Cardiotoxicity 12/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 03/2018
1	Fatigue 01/2017
1	Ovarian Epithelial Carcinoma 10/2016
1	Carcinogenesis 10/2016
1	Carcinoma (Carcinomatosis) 06/2016
1	Neoplasm Metastasis (Metastasis) 07/2015

Drug/Important Bio-Agent (IBA)

6	Hormones (Hormone)IBA 02/2023 - 07/2015
4	Phenobarbital (Luminal)FDA Link 11/2023 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
2	Estrogen ReceptorsIBA 02/2023 - 01/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 12/2020
2	ErbB Receptors (EGF Receptor)IBA 10/2022 - 03/2018
2	Carboplatin (JM8)FDA LinkGeneric 12/2020 - 01/2020
2	human ERBB2 proteinIBA 01/2019 - 10/2018
2	LigandsIBA 01/2019 - 03/2018
1	Epidermal Growth Factor (EGF)IBA 02/2023
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2021
1	durvalumabIBA 01/2021
1	Troponin T (Troponin T1)IBA 12/2020
1	Hemoglobins (Hemoglobin)IBA 12/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2020
1	Epirubicin (Ellence)FDA LinkGeneric 12/2020
1	pro-brain natriuretic peptide (1-76)IBA 12/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	ParaffinIBA 01/2019
1	erucylphosphocholineIBA 01/2019
1	130-nm albumin-bound paclitaxelIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	MicroRNAs (MicroRNA)IBA 10/2018
1	Metalloproteases (Metalloproteinases)IBA 03/2018
1	PlatinumIBA 03/2018
1	AmphiregulinIBA 03/2018
1	DisintegrinsIBA 03/2018
1	Cisplatin (Platino)FDA LinkGeneric 03/2018
1	antineoplaston A10 (A 10)IBA 01/2018
1	CytokinesIBA 07/2017
1	Phosphotransferases (Kinase)IBA 10/2016
1	Progesterone FDA LinkGeneric 06/2016
1	Aldo-Keto ReductasesIBA 06/2016
1	Nucleic AcidsIBA 10/2013

Therapy/Procedure

10	Neoadjuvant Therapy 12/2023 - 01/2018
10	Therapeutics 01/2023 - 06/2016
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
2	Radiotherapy 02/2024 - 02/2021
1	Heterologous Transplantation (Xenotransplantation) 01/2022
1	Mammaplasty (Breast Reconstruction) 02/2021
1	Immunotherapy 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018
1	Lymph Node Excision (Lymph Node Dissection) 01/2017
1	Segmental Mastectomy (Lumpectomy) 07/2015